TXRH:NASDAQTexas Roadhouse, Inc. Analysis
Data as of 2026-05-28 - not real-time
$181.49
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Texas Roadhouse delivered a strong first‑quarter, with revenue topping $1.6 billion and comparable‑sales up 7.1%, propelling the stock 12.9% higher over the past month. The company’s 12.8% year‑over‑year revenue growth, 6.85% profit margin and a solid 28.9% ROE underscore robust operating performance, while the dividend payout ratio of 44.5% suggests the 1.65% yield remains sustainable. Technically, the share price of $181.49 sits above the 20‑day (≈$172) and 50‑day (≈$167) moving averages, the RSI sits at a healthy 63, and the MACD histogram is positive, indicating continued bullish momentum, though volume is trending down and the price is nearing the $185 resistance level.
Valuation metrics tell a more cautious story: a trailing P/E of 29 and a forward P/E of 23.8 place the stock at a premium to peers, and a discounted cash‑flow fair‑value estimate of roughly $52 per share implies the market is pricing in significant growth expectations. The company carries a high debt‑to‑equity ratio (~68%) and a net‑debt position that exceeds cash balances, adding balance‑sheet risk, while the consumer‑cyclical nature of the restaurant sector introduces medium‑level sector risk. Overall, the stock appears slightly overvalued despite strong earnings momentum and a sustainable dividend.
Valuation metrics tell a more cautious story: a trailing P/E of 29 and a forward P/E of 23.8 place the stock at a premium to peers, and a discounted cash‑flow fair‑value estimate of roughly $52 per share implies the market is pricing in significant growth expectations. The company carries a high debt‑to‑equity ratio (~68%) and a net‑debt position that exceeds cash balances, adding balance‑sheet risk, while the consumer‑cyclical nature of the restaurant sector introduces medium‑level sector risk. Overall, the stock appears slightly overvalued despite strong earnings momentum and a sustainable dividend.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Price approaching $185 resistance with decreasing volume
- Bullish technical indicators (MACD, RSI, SMAs)
- High valuation relative to DCF fair value
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong Q1 earnings beat and revenue growth
- Analyst target median price of $196 indicating upside
- Sustainable dividend and solid ROE
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Durable brand and franchise model in a consumer‑cyclical sector
- Elevated debt levels that could limit flexibility
- Continued dividend payments supporting shareholder yield
Key Metrics & Analysis
Financial Health
Revenue Growth12.80%
Profit Margin6.85%
P/E Ratio29.0
ROE28.92%
ROA8.99%
Debt/Equity68.53
P/B Ratio7.9
Op. Cash Flow$751.4M
Free Cash Flow$190.2M
Technical Analysis
TrendNeutral
RSI63.0
Support$153.83
Resistance$185.10
MA 20$171.90
MA 50$167.12
MA 200$171.92
MACDBullish
VolumeDecreasing
Fear & Greed Index92.34
Valuation
Fair Value$52.22
Target Price$196.67
Upside/Downside8.36%
GradeOvervalued
TypeBlend
Dividend Yield1.65%
Risk Assessment
Beta0.61
Volatility42.05%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.